Oncopeptides AB's total assets for Q1 2025 were kr173.41M, a decrease of -28.99% from the previous quarter. SE:ONCO total liabilities were kr179.25M for the fiscal quarter, a -5.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.